EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $298,000 | -67.9% | 7,235 | -55.9% | 0.00% | -66.7% |
Q2 2021 | $928,000 | -87.2% | 16,388 | -90.5% | 0.00% | -88.5% |
Q1 2021 | $7,255,000 | -91.3% | 172,750 | -85.5% | 0.03% | -91.3% |
Q4 2020 | $83,812,000 | +131.7% | 1,195,408 | -7.2% | 0.30% | +109.1% |
Q3 2020 | $36,166,000 | +8.8% | 1,288,758 | +14.7% | 0.14% | +5.9% |
Q2 2020 | $33,233,000 | +62.7% | 1,123,484 | +9.1% | 0.14% | +42.1% |
Q1 2020 | $20,427,000 | -28.9% | 1,030,116 | +6.1% | 0.10% | -12.8% |
Q4 2019 | $28,749,000 | +34.9% | 970,957 | +3.6% | 0.11% | +25.3% |
Q3 2019 | $21,305,000 | +0.1% | 936,856 | +9.0% | 0.09% | -1.1% |
Q2 2019 | $21,275,000 | +22.5% | 859,885 | +22.5% | 0.09% | +22.2% |
Q1 2019 | $17,367,000 | +46.9% | 701,740 | +35.0% | 0.07% | +24.1% |
Q4 2018 | $11,824,000 | -26.0% | 519,819 | +3.5% | 0.06% | -12.1% |
Q3 2018 | $15,978,000 | -0.5% | 502,139 | +12.0% | 0.07% | -5.7% |
Q2 2018 | $16,057,000 | +23.2% | 448,148 | +13.9% | 0.07% | +20.7% |
Q1 2018 | $13,038,000 | – | 393,298 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |